We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$532M
AUM Growth
+$24M
Cap. Flow
+$3.61M
Cap. Flow %
0.68%
Top 10 Hldgs %
22.6%
Holding
125
New
2
Increased
45
Reduced
57
Closed
2

Top Buys

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$904K
2
PXD
Pioneer Natural Resource Co.
PXD
+$537K
3
DD icon
DuPont de Nemours
DD
+$447K
4
PG icon
Procter & Gamble
PG
+$439K
5
BUD icon
AB InBev
BUD
+$402K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.16M
2
DD
Du Pont De Nemours E I
DD
+$427K
3
BA icon
Boeing
BA
+$291K
4
WFM
Whole Foods Market Inc
WFM
+$229K
5
MCD icon
McDonald's
MCD
+$186K

Sector Composition

Rank Sector Weight
1 Healthcare 16.51%
2 Technology 15.73%
3 Industrials 12.88%
4 Communication Services 12.52%
5 Consumer Staples 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTS icon
76
Watts Water Technologies
WTS
$11.5B
$1.63M 0.31%
23,555
+50
+0.2% +$3.21K
PCAR icon
77
PACCAR
PCAR
$69.8B
$1.59M 0.3%
33,045
– –
QCOM icon
78
Qualcomm
QCOM
$155B
$1.55M 0.29%
8,337
-225
-3% -$11.9K
KDP icon
79
Keurig Dr Pepper
KDP
$42.3B
$1.46M 0.28%
16,545
– –
YUMC icon
80
Yum China
YUMC
$16.5B
$1.44M 0.27%
36,125
-200
-0.6% -$7.45K
DD icon
81
DuPont de Nemours
DD
$18.5B
$1.35M 0.25%
7,716
+2,681
+53% +$447K
COP icon
82
ConocoPhillips
COP
$147B
$1.15M 0.22%
23,021
-1,650
-7% -$74.1K
REGN icon
83
Regeneron Pharmaceuticals
REGN
$78.5B
$1.13M 0.21%
35,457
-2,440
-6% -$1.16M
ORCL icon
84
Oracle
ORCL
$374B
$1.11M 0.21%
22,929
– –
VIAB
85
DELISTED
Viacom Inc. Class B
VIAB
$985K 0.19%
35,388
-870
-2% -$26.8K
TGT icon
86
Target
TGT
$65.6B
$974K 0.18%
16,513
-450
-3% -$25.2K
CL icon
87
Colgate-Palmolive
CL
$73.1B
$853K 0.16%
11,712
– –
SNY icon
88
Sanofi
SNY
$103B
$807K 0.15%
16,225
-140
-0.9% -$6.77K
WFC icon
89
Wells Fargo
WFC
$261B
$704K 0.13%
12,780
-550
-4% -$29.2K
UNFI icon
90
United Natural Foods
UNFI
$3.08B
$682K 0.13%
16,404
-770
-4% -$28.7K
BP icon
91
BP
BP
$116B
$653K 0.12%
18,857
-325
-2% -$10.3K
TWX
92
DELISTED
Time Warner Inc
TWX
$598K 0.11%
5,838
-50
-0.8% -$5.07K
PM icon
93
Philip Morris
PM
$297B
$471K 0.09%
4,250
– –
WMT icon
94
Walmart Inc
WMT
$885B
$392K 0.07%
15,075
– –
PSX icon
95
Phillips 66
PSX
$84.9B
$372K 0.07%
4,068
– –
BAC icon
96
Bank of America
BAC
$435B
$360K 0.07%
14,224
– –
HPQ icon
97
HP
HPQ
$24.9B
$347K 0.07%
17,400
-100
-0.6% -$1.9K
PCG icon
98
PG&E
PCG
$38.3B
$347K 0.07%
5,100
-200
-4% -$13.7K
MPC icon
99
Marathon Petroleum
MPC
$92.4B
$342K 0.06%
6,100
– –
RTN
100
DELISTED
Raytheon Company
RTN
$335K 0.06%
750
– –
1 2 3
4
5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Jacobs & Co held 125 positions worth $532M, up 4.7% from $508M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 3.2%. Jacobs & Co opened 2 new positions and exited 2, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Jacobs & Co's largest Q3 2017 buy was Lockheed Martin: 748 shares worth $232K.
  • Jacobs & Co added most to Newell Brands in Q3 2017, an estimated $904K increase.
  • Jacobs & Co's biggest Q3 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.16M.
  • Jacobs & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $427K.
  • Jacobs & Co's ten largest holdings make up 23% of its $532M portfolio in Q3 2017.
  • Jacobs & Co opened 2 new positions and closed 2 in Q3 2017.
  • Jacobs & Co's portfolio value rose 4.7% quarter-over-quarter to $532M.

Based on Jacobs & Co's 13F filing for Q3 2017, filed 14 Nov 2017.